Skip to content

  • Current Fragile X Research Grants
  • Personal Campaigns
  • Request For Applications – Research Grants
FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome

FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome

Accelerating Fragile X Research for Effective Treatments

Donate
  • What is Fragile X?
    • About Fragile X Syndrome
      • What Is Fragile X Syndrome?
      • Symptoms
      • Physical Signs
      • Prevalence and Inheritance
      • Fragile X and Autism
      • Treatment
      • Additional Resources
    • Understanding Fragile X Syndrome
      • What Causes Fragile X Syndrome?
      • The Fragile X Gene
      • Testing/Diagnosis
        • Prenatal Testing
      • Fragile X-Associated Disorders – FXTAS and FXPOI
    • Inspiration
      • #FriendofFRAXA
        • #FriendofFRAXA Submission
      • FRAXA in the News
  • News & Updates
  • Research
    • How Close Are We to a Cure?
    • Curative Therapies Fund
    • Funded Research Grants
    • Fragile X Clinical Trials
    • How to Apply for Research Grants
    • Resources for Researchers
  • Get Involved
    • Stay Connected
      • Attend a Fragile X Event
      • Subscribe to Newsletter
      • Share Your Pictures or Videos With Us
    • Take Action
      • World Fragile X Day
      • Personal Fundraising Campaigns
      • Run Your Own Event
      • Volunteer for FRAXA
        • Advocate for Fragile X
      • FRAXA Shop
    • Participate in Fragile X Research
      • Fragile X Clinical Trials
      • Fragile X Biomarker Research – COMBINEDBrain Consortium
      • Fragile X Clinics
  • About FRAXA
    • Mission Statement
    • Give with Confidence
    • Financial Reports
    • FRAXA in the News
    • Board & Leadership
    • Scientific Advisors
    • FRAXA’s Fragile X Timeline
  • Donate
    • Donate Online
    • Monthly Giving Program
    • Give to a Personal Campaign
    • Other Ways to Give

Author: FRAXA Research Foundation

Role of Microglia in Fragile X Syndrome

FRAXA Research Foundation June 26, 2025June 26, 2025
Marine Anais Krzisch, PhD

Learn how Dr. Marine Anais Krzisch’s $35K FRAXA and ASF-funded project uses human iPSC microglia models to uncover pathways for Fragile X syndrome treatment.

Read more

Modeling R-Loop Therapy for Fragile X Syndrome in Patient-Derived Brain Organoids

FRAXA Research Foundation June 18, 2025
Jeannie Lee, MD, PhD and Chloe Chen, PhD

Fragile X syndrome researchers model R-loop therapy in patient-derived brain organoids to restore FMR1, accelerating a curative approach supported by FRAXA.

Read more

UMass Chan Medical School Licenses RNA-Based Therapy to QurAlis, Advancing a New Era in Fragile X Treatment

FRAXA Research Foundation June 5, 2025

UMass Chan Medical School licenses RNA-based Fragile X treatment approach using ASOs to QurAlis, moving a groundbreaking gene-targeted therapy closer to human clinical trials.

Read more

Harvard’s Dr. Jeannie Lee Wins $1M Award to Develop Gene Reactivation Therapy for Fragile X

FRAXA Research Foundation May 30, 2025June 2, 2025
Dr. Jeannie Lee standing in front of a staircase at Harvard Medical School, recipient of the Blavatnik $1M award for Fragile X gene reactivation research

Dr. Jeannie Lee wins $1M Blavatnik Award to advance FMR1 gene reactivation therapy for Fragile X, building on years of FRAXA-funded research.

Read more

#teamwally: Help Find a Cure for Fragile X Syndrome

FRAXA Research Foundation May 9, 2025May 9, 2025
#teamwally gathered in matching Fragile X shirts for a group photo during a family fundraiser

Join #teamwally in supporting Fragile X research. Read Wally’s inspiring journey and help fund a future of hope and breakthroughs for kids like him.

Read more

New Research Targets NMDA Receptor – A Key Player in Brain Communication and Fragile X Syndrome

FRAXA Research Foundation April 30, 2025
High-resolution image of dendritic spines—tiny structures on neurons that are altered in Fragile X syndrome.

Fragile X syndrome research identifies NMDA receptor as a promising treatment target, with drugs already in trials offering faster paths to human studies.

Read more

Fragile X and Fatigue: Study Reveals How Muscle Function is Altered in Children

FRAXA Research Foundation April 16, 2025
Researcher analyzing gait patterns on a treadmill for Fragile X syndrome motor function study.

FRAXA-funded research shows how Fragile X syndrome muscle function affects walking and fatigue, offering insights for future treatments.

Read more

Fragile X and PDE Inhibitors: A Promising Path Forward for Brain Disorders

FRAXA Research Foundation March 26, 2025
Dr. Thomas Maurin and Dr. Barbara Bardoni, Fragile X researchers and co-authors of a 2025 review on PDE inhibitors published in Cell Reports Medicine.

Fragile X syndrome research shows PDE inhibitors may improve brain function and behavior, with promise for related neurodevelopmental disorders.

Read more

Shionogi’s EXPERIENCE Phase 3 Clinical Trial of Zatolmilast in Fragile X Syndrome

FRAXA Research Foundation March 21, 2025May 19, 2025

Shionogi’s EXPERIENCE clinical trials for Fragile X syndrome are nearing completion. Enrollment for the adult trial (EXPERIENCE-301) is now closed, while the adolescent trial (EXPERIENCE-204) is in its final phase. Learn more about the study, FRAXA’s role, and the open-label extension.

Read more

Urgent Action Needed: Help Secure NIH Funding for Fragile X Research

FRAXA Research Foundation March 13, 2025March 13, 2025

NIH funding delays are threatening Fragile X research, putting critical studies and future treatments at risk. FRAXA Research Foundation and NFXF are urging Congress and the NIH to act now. Learn how you can help secure funding for Fragile X research.

Read more

Advancing Curative Therapy for Fragile X Syndrome: Turner Lab Secures $1M Grant

FRAXA Research Foundation March 10, 2025

Fragile X syndrome research accelerates as the Turner Lab secures $1M to expand FRAXA-funded work on curative therapy targeting the missing FMRP protein.

Read more

Help Direct Millions in Fragile X Research Funding – DOD Seeks Reviewers

FRAXA Research Foundation February 17, 2025February 28, 2025

The DOD’s Fragile X syndrome research program seeks reviewers to help evaluate funding applications. No science background needed—apply by March 7!

Read more

GEXVal and FRAXA Collaborate to Advance Fragile X Research with Phase 2a Trial

FRAXA Research Foundation January 2, 2025January 2, 2025

GEXVal and FRAXA collaborate to advance Fragile X research with the Phase 2a trial of GXV-001, supported by AMED’s funding program.

Read more

Help Rowan Thrive: Support Fragile X Research

FRAXA Research Foundation December 12, 2024December 15, 2024
Rowan, a young girl with Fragile X syndrome, standing with her family at a scenic outdoor location, symbolizing love and support.

Join the Gale family in supporting Fragile X research through FRAXA. Help Rowan and others thrive by funding life-changing treatments and advancing curative therapies.

Read more

Honor Cooper’s Birthday with a Donation to Fragile X Research

FRAXA Research Foundation November 14, 2024

Honor Cooper’s birthday by donating to Fragile X syndrome research. Every contribution supports new treatments and hope for a brighter future.

Read more

Support the FRAXA Schutz Family Campaign & #teamwally Campaign

FRAXA Research Foundation November 11, 2024May 8, 2025

Join the Schutz family in their journey with Fragile X syndrome. Discover Wally’s inspiring progress, the impact of clinical research, and how donations to FRAXA fuel hope for breakthroughs to support families affected by Fragile X.

Read more

Donate to the Clark Family Campaign

FRAXA Research Foundation November 5, 2024December 2, 2024

Join Stefanie Clark’s heartfelt appeal to support Fragile X research. Help fund breakthroughs for Lucas and others like him. Every dollar makes a difference — donate today!

Read more

Support the Stevenson Family Campaign

FRAXA Research Foundation November 4, 2024November 6, 2024

The march of time renews the commitment we made to a special needs community 25 years ago. We vowed to dream big and never give up until there were effective treatments available and eventually a cure for Fragile X syndrome, the most commonly inherited cause of intellectual disabilities and autism.

Read more

BK Channel Openers: A New Hope for Fragile X Treatment – Insights from Kaerus Bioscience CEO Robert Ring

FRAXA Research Foundation October 22, 2024

Kaerus Bioscience’s BK channel openers for Fragile X syndrome are advancing through Phase 1 trials, offering hope for new treatments with FRAXA’s continued support.

Read more

Investigating the Role of the Insulin Degrading Enzyme (IDE) in Fragile X Syndrome

FRAXA Research Foundation October 7, 2024June 26, 2025

FRAXA Research Foundation awards a $100,000 grant to Ludwig Maximilian University researchers to investigate the role of insulin-degrading enzyme (IDE) in Fragile X syndrome, exploring new therapeutic approaches for cognitive and metabolic challenges in FXS.

Read more

NPR Spotlights Zatolmilast: A Potential Breakthrough for Fragile X Syndrome

FRAXA Research Foundation October 1, 2024April 21, 2025

NPR spotlights zatolmilast, a promising drug offering new hope for individuals with Fragile X syndrome. Families report life-changing improvements in anxiety, communication, and independence.

Read more

Altered Physiology of Primary Visual Cortex in Fragile X Syndrome

FRAXA Research Foundation September 19, 2024May 30, 2025
Mark Bear, PhD & Sara Kornfeld Simpson

Discover how a $100,000 FRAXA grant supports research at MIT targeting neuron dysfunction in Fragile X, aiming to develop new therapies to improve sensory processing and behavior.

Read more

Gene Editing of FMR1 to Correct FXS Phenotypes in Mice

FRAXA Research Foundation September 5, 2024May 30, 2025

FRAXA awarded a $100,000 grant to Dr. Davidson and Dr. Yrigollen at Children’s Hospital of Philadelphia to explore gene editing tools aimed at treating Fragile X syndrome by correcting FMR1 mutations in a unique mouse model.

Read more

Fragile X Unplugged: Establishing Mobile EEG as the Next Frontier

FRAXA Research Foundation August 21, 2024November 19, 2024

Discover how a $100,000 FRAXA grant awarded to Cincinnati Children’s Hospital is advancing Fragile X research by simplifying EEG technology for home use, improving clinical trial accessibility and efficiency.

Read more

Marvel Biosciences Partners with FRAXA to Test MB204 for Fragile X Syndrome

FRAXA Research Foundation August 20, 2024August 30, 2024

Discover how Marvel Biosciences and FRAXA Research Foundation are collaborating to test MB204, a promising new treatment for Fragile X syndrome, building on groundbreaking adenosine receptor research.

Read more
  • ← Previous

FRAXA Research Foundation

  • 10 Prince Place, Suite 203
    Newburyport, MA 01950-2657
  • info@fraxa.org
  • (978) 462-1866
Donate Online
GuideStar_Exchange-Platinum_Participant
GreatNonprofits 2024 top rated award - FRAXA Research Foundation
charity_navigator-4_star_charity

Join our Newsletter Mailing List

Name*
This field is for validation purposes and should be left unchanged.

Copyright © 2025 FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome
FRAXA Research Foundation is a registered 501(c)3 organization.
Tax ID: 04-3222167

Change Privacy Settings

  • Privacy Policy
  • Cookie Policy
  • About Fragile X
  • Ways to Give